Explore our resource portfolio

On-demand webinars

Patient in the lab®: downscaling patient-derived organoid screening

organoid screening

Patient in the lab®: downscaling patient-derived organoid screening

René Overmeer, Head of Assay Development and Automation HUB Organoids

Model human disease and identify predictive biomarkers of response

organoid screening

Model human disease and identify predictive biomarkers of response

Robert Vries, CEO HUB Organoids

HUB's blog

PDO Screen – Patient-derived Organoids meet Cancer Modeling

Blog

PDO Screen – Patient-derived Organoids meet Cancer Modeling

Discover how patient-derived organoids can revolutionize oncology research by enabling accurate modeling of tumor biology and predicting patient response to...

The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development

Blog

The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development

Explore what the new legislative bill means for the future of organoid technology in drug development The use of animals...

Challenges in preclinical modeling of cancer immunity

Blog

Challenges in preclinical modeling of cancer immunity

Learn how to select the right model for your immunotherapy development Over the past decade, immunotherapy has revolutionized oncology. From...

X

Have any questions?

contact us